Global Clinical Trial Imaging Market 2019-2026 By Major Key Players BioTelemetry, Inc, IXICO plc, Resonance Health, Bioclinica, ICON plc, Radiant Sage LLC

Global Clinical Trial Imaging Market report is a synopsis on the study of the Pharmaceutical industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. The report directly focuses on all the key players and brands as their moves can always make a difference when it comes to sales, import, export, and revenue at a global level because of their recent developments, product launches, research, joint ventures, mergers, and acquisitions.

The report also takes the help of SWOT analysis when to come to finding all the drivers and restraints of the Clinical Trial Imaging Market, while also showing all the CAGR levels of the historic year 2017, the base year 2018 and forecast year 2019-2026.

Get PDF Sample Copy of Global Clinical Trial Imaging Market Report at https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-clinical-trial-imaging-market

The global clinical trial imaging market is projected to register a substantial CAGR of 6.7% in the forecast period of 2019 to 2026. Global Clinical Trial Imaging Market By Product & Services (Services, Software), Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Others), Application (Oncology, Neurology, Endocrinology, Cardiology, Dermatology, Hematology, Others), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic and Government Research Institutes, Medical Device Manufacturers, Others), Distribution Channel (Direct Sales, Tender Sales), Geography (Europe, North America, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Some of the major players operating in this market are

BioTelemetry, Inc,
IXICO plc,
Resonance Health,
Bioclinica,
ICON plc,
Radiant Sage LLC,
Lyscaut Medical Imaging Company,
Quotient Sciences,
worldcare Clinical,
Navitas Life Sciences,
Cardiovascular Imaging Technologies,
Intrinsic Imaging,
Image Core Lab,
ERT Clinical,
Perspectum Diagnostics,
Anagram 4 clinical trials,
Parexel International Corporation among others.

Imaging techniques are highly used in oncological clinical trials for gaining accurate evidences in order to make a good decision. In the clinical trial imaging, the technology of imaging representations for medical includes the service of radiographers (X-ray technologists), medical physicists, radiologists, sonographers (ultrasound technologists), nurses and biomedical engineers.

The first computer-based image analysis was introduced in the year 1960. Initially medical imaging was started with the technology of X-rays, at that time the procedure of X-ray would be passed through the body onto some film, which would generate an image and it would take around 11 minutes to complete the procedure of X-ray. Digitalization technique was introduced in 1970. This new technique contains digital image of the inner parts of the body such as computed tomography scanner. This digital technique has many benefits such as ease of storing records, it has the ability to use computers to analyze images and detect issues and it has the ability to enhance images with the use of technology.

Segmentation: Global Clinical Trial Imaging Market

Global clinical trial imaging market is segmented into five notable segments which are basis of product & services, modality, application, end user and distribution channel.

On the basis of product & services, the market is segmented into services and software

In May 2019, Navitas Life Cycle announces acquisition of KAI Research which strengthens its expertise in pain, diabetes, infectious diseases and mental health and intends to create an enterprise to deliver and initiate trial outcomes.

On the basis of modality, the market is segmented into computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography and others

On the basis of application, the market is segmented into oncology, neurology, endocrinology, cardiology, dermatology, hematology and others

On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic and government research institutes, medical device manufacturers and others

In August 2019, IXICO PLC announced that they have entered in a contract with two new biopharmaceutical clients for the provision of data analytics services which helps in supporting clinical trials in Europe and North America. By this contract with biopharmaceutical clients, the company has enhanced their credibility in the market.

On the basis of distribution channel, the market is segmented into direct sales and tender sales

Enquire for Buying Global Clinical Trial Imaging Market Report at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-clinical-trial-imaging-market

Table of Contents:

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL CLINICAL TRIAL IMAGING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GLOBAL CLINICAL TRIAL IMAGING MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 GLOBAL CLINICAL TRIAL IMAGING MARKET: DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.1 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING R&D EXPENDITURE

3.1.2 INCREASING NUMBER OF CONTRACT RESEARCH ORGANIZATION

3.1.3 INCREASING PREVALENCE OF CHRONIC DISEASES

3.1.4 GROWTH IN THE PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES

3.2 RESTRAINTS

3.2.1 HIGH RISK RADIATION CAUSING DISEASES

3.2.2 HIGH IMPLEMENTATION COST OF IMAGING SYSTEMS

3.3 OPPORTUNITIES

3.3.1 STRATEGIC INITIATIVES FOR BUSINESS EXPANSION

3.3.2 DEVELOPMENT OF INNOVATIVE IMAGING MODALITIES AND CONTRAST AGENTS

3.3.3 EMERGING ECONOMIES

3.4 CHALLENGES

3.4.1 STRICT REGULATORY POLICIES

3.4.2 COST OF CLINICAL TRIALS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL CLINICAL TRIAL IMAGINGMARKET, BY PRODUCT AND SERVICES

6.1 OVERVIEW

6.2 SERVICES

6.2.1 OPERATIONAL IMAGING SERVICES

6.2.2 READ ANALYSIS SERVICES

6.2.3 TRIAL DESIGN CONSULTING SERVICES

6.2.4 SYSTEM AND TECHNICAL SUPPORT SERVICES

6.3 SOFTWARE

7 GLOBAL CLINICAL TRIAL IMAGING MARKET, BY APPLICATION

8 GLOBAL CLINICAL TRIAL IMAGINGMARKET, BY MODALITY

9 GLOBAL CLINICAL TRIAL IMAGINGMARKET, BY END USER

9.1 OVERVIEW

9.2 CONTRACT RESEARCH ORGANIZATION

9.3 MEDICAL DEVICE MANUFACTURERS

9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9.5 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

10 GLOBAL CLINICAL TRIAL IMAGING MARKET, BY DISTRIBUTOR

10.1 OVERVIEW

10.2 DIRECT SALES

10.3 TENDERS SALES

11 GLOBAL CLINICAL TRIAL IMAGING MARKET, BY GEOGRAPHY

12 GLOBAL CLINICAL TRIAL IMAGING MARKET, COMPANY LANDSCAPE

13 COMPANY PROFILE
14 QUESTIONNAIRE

15 RELATED REPORTS

View Detailed Table of Contents at https://www.databridgemarketresearch.com/toc/?dbmr=global-clinical-trial-imaging-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.